114 related articles for article (PubMed ID: 5560183)
1. Presence of a myocardial depressant factor in patients in circulatory shock.
Lovett WL; Wangensteen SL; Glenn TM; Lefer AM
Surgery; 1971 Aug; 70(2):223-31. PubMed ID: 5560183
[No Abstract] [Full Text] [Related]
2. Role of the pancreas in the pathogenesis of circulatory shock.
Lefer AM; Glenn TM
Adv Exp Med Biol; 1971 Oct; 23(0):311-35. PubMed ID: 5006110
[No Abstract] [Full Text] [Related]
3. Production of a myocardial depressant factor in cardiogenic shock.
Glenn TM; Lefer AM; Martin JB; Lovett WL; Morris JN; Wangensteen SL
Am Heart J; 1971 Jul; 82(1):78-85. PubMed ID: 5581723
[No Abstract] [Full Text] [Related]
4. Oxyhemoglobin dissociation curve in hemorrhagic and septic shock.
Valeri CR; Kopriva CJ
Adv Exp Med Biol; 1971 Oct; 23(0):177-93. PubMed ID: 5164834
[No Abstract] [Full Text] [Related]
5. Mechanism of the protective effects of prostaglandins E1 and F2 alpha in canine endotoxin shock.
Raflo GT; Wangensteen SL; Glenn TM; Lefer AM
Eur J Pharmacol; 1973 Oct; 24(1):86-95. PubMed ID: 4585594
[No Abstract] [Full Text] [Related]
6. Role of a myocardial depressant factor in the pathogenesis of circulatory shock.
Lefer AM
Fed Proc; 1970; 29(6):1836-47. PubMed ID: 5482718
[No Abstract] [Full Text] [Related]
7. Significance of splanchnic proteases in the production of a toxic factor in hemorrhagic shock.
Glenn TM; Lefer AM
Circ Res; 1971 Oct; 29(4):338-49. PubMed ID: 4329372
[No Abstract] [Full Text] [Related]
8. Myocardial metabolism during acute shock induced by hemorrhage, endotoxin, or physostigmine infusion.
Spitzer JJ
Recent Adv Stud Cardiac Struct Metab; 1973; 3():161-7. PubMed ID: 4619693
[No Abstract] [Full Text] [Related]
9. Shock.
Gill W; Long WB
J R Coll Surg Edinb; 1972 Sep; 17(5):304-14. PubMed ID: 4561808
[No Abstract] [Full Text] [Related]
10. Pteridine and nitrite/nitrate formation in experimental septic and traumatic shock.
Strohmaier W; Werner ER; Wachter H; Redl H; Schlag G
Shock; 1996 Oct; 6(4):254-8. PubMed ID: 8902941
[TBL] [Abstract][Full Text] [Related]
11. [Pathogenesis of the septic-toxic shock].
Bartel J
Z Arztl Fortbild (Jena); 1972 Aug; 66(15):753-8. PubMed ID: 4351993
[No Abstract] [Full Text] [Related]
12. Use of monitoring to improve survival in shock.
Niazi A; Beckman C; Shatney C; Lillehei RC
Geriatrics; 1975 Jul; 30(7):93-108. PubMed ID: 1140572
[No Abstract] [Full Text] [Related]
13. Clinical shock: a hemodynamic and metabolic assessment of treatment.
McLaughlin JS; Santos D; Khazei H; Attar S; Mansberger A; Cowley RA
Am Surg; 1967 Sep; 33(9):687-95. PubMed ID: 6036381
[No Abstract] [Full Text] [Related]
14. Altered mitochondrial metabolism in circulatory shock.
Mela L
Adv Exp Med Biol; 1977; 78():371-3. PubMed ID: 19942
[No Abstract] [Full Text] [Related]
15. Mechanism of the lack of a beneficial response to inotropic drugs in hemorrhagic shock.
Lefer AM; Glenn TM; Lopez-Rasi AM; Kiechel SF; Ferguson WW; Wangensteen SL
Clin Pharmacol Ther; 1971; 12(3):506-16. PubMed ID: 5567802
[No Abstract] [Full Text] [Related]
16. Influence of hemodialysis on a myocardial depressant factor in hemorrhagic shock.
Wangensteen SL; DeHoll JD; Kiechel SF; Martin J; Lefer AM
Surgery; 1970 Jun; 67(6):935-43. PubMed ID: 5429578
[No Abstract] [Full Text] [Related]
17. Serum myocardial depressant factor of burn shock.
Baxter CR; Cook WA; Shires GT
Surg Forum; 1966; 17():1-2. PubMed ID: 5920908
[No Abstract] [Full Text] [Related]
18. Cardiovascular dynamics in human shock.
McLaughlin JS; Shama Z; Hirsch E; Khazei AH; Attar S; Cowley A
Am Surg; 1969 Mar; 35(3):166-76. PubMed ID: 5774446
[No Abstract] [Full Text] [Related]
19. [Oxygen consumption of the entire organism in animal and human shock].
Neuhof H; Glaser E
Verh Dtsch Ges Inn Med; 1969; 75():383-6. PubMed ID: 5400160
[No Abstract] [Full Text] [Related]
20. Beneficial action of new angiotensin-converting enzyme inhibitor (SQ 14,225) in hemorrhagic shock in cats.
Trachte GJ; Lefer AM
Circ Res; 1978 Oct; 43(4):576-82. PubMed ID: 210975
[No Abstract] [Full Text] [Related]
[Next] [New Search]
